The neuropeptides, VIP and NPY, that are present in the thyroid nerves are not released into the thyroid vein

Thyroid

Volumn 8, Issue 11, 1998, Pages 1071-1077

  Michalkiewicz, Mieczyslaw ^a   Dey, Malay ^a   Huffman, Linda J ^b   Hedge, George A ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE; LIOTHYRONINE; NEUROPEPTIDE; NEUROPEPTIDE Y; NORADRENALIN; THYROID HORMONE; THYROXINE; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD FLOW; CONTROLLED STUDY; DIETARY INTAKE; ELECTROSTIMULATION; GANGLION; HORMONE RELEASE; LASER DOPPLER FLOWMETRY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUPERIOR LARYNGEAL NERVE; SYMPATHETIC TRUNK; THYROID GLAND; VENOUS BLOOD;

EID: 0031773203     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1998.8.1071     Document Type: Article

References (41)

1. Ahren B, Alumets J, Ericsson M, Fahrenkrug J, Fahrenkrug L, Hakanson R, Hedner P, Loren I, Melander A, Rerup C, Sundler F 1980 VIP occurs in thyroidal nerves and stimulates thyroid hormone secretion. Nature 287:343-345.
2. Hedge G, Huffman LJ, Grunditz T, Sundler F 1984 Immunocytochemical studies of the peptidergic innervation of the thyroid gland in the Brattleboro rat. Endocrinology 115:2071-2076.
3. Grunditz T, Hakanson R, Rerup C, Sundler F, Uddman R 1984 Neuropeptide Y in the thyroid gland: Neuronal localization and enhancement of stimulated thyroid hormone secretion. Endocrinology 115:1537-1542.
4. Grunditz T, Hakanson R, Sundler F, Uddman R 1988 Neuronal pathways to the rat thyroid revealed by retrograde tracing and immunocytochemistry. Neuroscience 24:321-335.
5. Pietrzyk Z, Michalkiewicz M, Huffman LJ, Hedge GA 1992 Vasoactive intestinal peptide enhances thyroid iodide uptake during dietary iodine deficiency. Endocr Res 18:213-228.
6. Huffman L, Hedge GA 1986 Effects of vasoactive intestinal peptide on thyroid blood flow and circulating thyroid hormone levels in the rat. Endocrinology 118:550-557.
7. Hedge GA, Huffman LJ, Connors JM 1986 Functional significance of peptidergic thyroid nerves. In: SM McCann, RI Weiner (eds) Integrative Neuroendocrinology: Molecular, Cellular and Clinical Aspects. Karger, Basel, pp 115-126.
8. Imada M, Kurosumi M, Fujita H 1986 Three-dimensional aspects of blood vessels in thyroids from normal, low iodine diet-treated, TSH-treated, and PTU-treated rats. Cell Tissue Res 245:291-296.
9. Michalkiewicz M, Huffman LJ, Connors JM, Hedge GA 1989 Alterations in thyroid blood flow induced by varying levels of iodine intake in the rat. Endocrinology 125:54-60.
10. Michalkiewicz M, Connors JM, Huffman LJ, Pietrzyk Z, Hedge GA 1990 Is thyroid blood flow a limiting factor for thyroid iodine supply? In: Drexhage H, de Vijlder J, Wiersinga W (eds) The Thyroid Gland, Environment, and Autoimmunity. Excerpta Medica, Amsterdam, p 129.
11. Dey M, Michalkiewicz M, Huffman LJ, Hedge GA 1993 Thyroidal vascular responsiveness to parasympathetic stimulation is increased in hyperthyroidism. Am J Physiol 264: E398-E402.
12. Dey M, Michalkiewicz M, Huffman LJ, Hedge GA 1993 Neuropeptide Y is not a primary mediator of the thyroid blood flow response to sympathetic nerve stimulation. Am J Physiol 265:E24-E30.
13. Dey M, Michalkiewicz M, Huffman LJ, Hedge GA 1993 Sympathetic thyroidal vasoconstriction is not blocked by a neuropeptide Y antagonist or antiserum. Peptides 14:1179-1186.
14. Öberg PA 1989 Innovations and precautions. In: Shepherd AP (ed) Laser-Doppler Blood Flowmetry. Kluwer Academic Publishers, New York, p 93.
15. Michalkiewicz M, Huffman LJ, Dey M, Hedge GA 1993 Endogenous neuropeptide Y regulates thyroid blood flow. Am J Physiol 264 (Endocrinol. Metab 27):E699-E705.
16. Michalkiewicz M, Huffman LJ, Malay D, Hedge GA 1994 Immunization against vasoactive intestinal peptide does not affect thyroid hormone secretion or thyroid blood flow. Am J Physiol 266:E905-E913.
17. Huffman LJ, Michalkiewicz M, Vrana KE, Hedge GA 1992 Expression of preproNPY and precursor VIP mRNAs in rats under hypo- or hyperthyroid conditions. Mol Cell Neurosci 3:418-424.
18. Lundberg JM, Rudehill A, Sollevi A, Theodosrsson E, Hamberger B 1986 Frequency and reserpine dependent chemical coding of sympathetic transmission: Differential release of noradrenaline and neuropeptide Y from pig spleen. Neurosci Lett 63:96-100.
19. Custagne V, Corder R, Gaillard R, Mormede P 1987 Stressinduced changes of circulating neuropeptide Y in the rat: Comparison with catecholamines. Regul Pept 19:55-63.
20. Lundberg JM, Martinsson A, Hemsen A, TheodorssonNorheim E, Svendenhag J, Ekblom B, Hjemdahl P 1985 Corelease of neuropeptide Y and catecholamines during physical exercise in man. Biochem Biophys Res Commun 133:30-36.
21. Morris JL, Kampoor V, Chalmers J 1987 Plasma neuropeptide Y concentrations are increased after hemorrhage in conscious rats: Relative contribution of sympathetic nerves and the adrenal medulla. J Cardiovasc Pharmacol 9:541-545.
22. Howe PR, Rogers PF, Morris MJ, Chalmers JP, Smith RM 1986 Plasma catecholamines and NPY as indices of sympathetic nerve activity in normotensive and stroke-prone spontaneously hypertensive rats. J Cardiovasc Pharmacol 8:1113-1121.
23. Solt VB, Brown MR, Kennedy B, Kolterman OG, Ziegler MG 1990 Elevated insulin, noepinephrine, and neuropeptide Y in hypertension. Am J Hypertens 3:823-828.
24. Taborsky GJ, Beltramini LM, Brown M, Veith RC, Kowalyk S 1994 Canine liver releases neuropeptide Y during sympathetic nerve stimulation. Am J Physiol 266:E804-E812.
25. Kong JY, Thureson-Klein AK, Klein RL 1990 Are NPY and enkephalins costored in the same noradrenergic neurons and vesicles? Peptides 11:565-575.
26. Poncet MF, Damase-Michel C, Tavernier G, Tran MA, Berlan M, Montastruc JL, Montastruc P 1991 Changes in plasma catecholamine and neuropeptide Y levels after sympathetic activation in dogs. Br J Pharmacol 105:181-183.
27. Tavernier G, Damas-Michel C, Portolan G, Tran MA, Montastruc JL 1992 Is neuropeptide Y co-released with catecholamines in experimental arterial hypertension following sinoaortic denervation? Arch Pharmacol 345:431-436.
28. Lundberg JM, Pernow J, Fried G, Änggärd A 1987 Neuropeptide Y and noradrenaline mechanism in relation to reserpine induced impairment of sympathetic neurotransmission in the cat spleen. Acta Physiol Scand 131:1-10.
29. Michalkiewicz M, Huffman LJ, Hedge GA 1991 Lack of effect of VIP antagonists on hormone secretion and blood flow in the rat thyroid. Peptides 12:1181-1186.
30. Wright RD, Blair-West JR, Gibson AP, Shulkes A 1991 Evidence against the involvement of VIP in ovine parotid secretion and blood flow. Clin Exp Pharmacol Physiol 18:469-474.
31. Lee TJF 1987 Evidence for and against VIP as a transmitter for vasodialtion in cerebral blood vessels. In: Edvinsson L (ed) Peptidergic Mechanism in the Cerebral Circulation. pp 65-74. VCH Publishers, New York.
32. Reid AM, Shulkes A, Titchen DA 1988 Effects of the vagus nerves on gastric motility and release of VIP in the anaesthetized lamb. J Physiol 396:11-24.
33. Lundberg JM, Änggärd A, Fahrenkrug J, Lundgren G, Holmstedt B 1982 Corelease of VIP and acetylcholine in relation to blood flow and salivary secretion in cat submandibular salivary gland. Acta Physiol Scand 115:525-528.
34. Ito H, Matsuda K, Sato A, Tohgi H 1987 Cholinergic and VIPergic vasodilator actions of parasympathetic nerves on the thyroid blood flow in rats. Jpn J Physiol 37:1005-1017.
35. Pernow J, Lundberg J, Kaijser M 1987 Vasoconstrictor effects in vivo and plasma disappearance rate of neuropeptide Y in man. Life Sci 40:47-54.
36. Griffiths EC, McDermott JR 1984 Biotransformation of neuropeptides. Neuroendocrinology 39:573-581.
37. Kobayashi R, Chen Y, Lee TD, Davis MT, Ito O, Walsh JH 1994 Degradation of vasoactive intestinal polypeptide by rabbit gastric smooth muscle membranes. Peptides 15:323-32.
38. Medeiros MS, Turner AJ 1994 Post-secretory processing of regulatory peptides: the pancreatic polypeptide family as a model example. Biochimie 76:283-287.
39. Mentlein R, Roos T 1996 Proteases involved in the metabolism of angiotensin II, bradykinin, CGRP, and neuropeptide Y. Peptides 17:709-720.
40. Fukuda H, Yasuda N, Greer MA, Kutas M, Greer SE 1975 Changes in plasma thyroxine, triiodothyronine, and TSH during adaptation to iodine deficiency in the rat. Endocrinology 97:307-314.
41. Janseen K, van der Heide D, Visser TJ, Kaptein E, Beynen AC 1994 Thyroid function and deiodinase activities in rats with marginal iodine deficiency. Biol Trace Elem Res 40:237-246.